๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Carbohydrate Biotechnology Protocols

โœ Scribed by Christopher Bucke


Publisher
Humana Press
Year
1999
Tongue
English
Leaves
419
Series
Methods in Biotechnology
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


Univ. of Westminster, London, UK. Methods for the use of microbes and enzymes to produce and modify carbohydrates of potential and actual commercial value. For new and experienced researchers. Includes methods for producing cyclic oligosaccharides, the FACE method for determining carbohydrate structures, and more.


๐Ÿ“œ SIMILAR VOLUMES


Carbohydrate Biotechnology Protocols
โœ Christopher Bucke ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐Ÿ› Humana Press ๐ŸŒ English

A compilation of modern hands-on methods using microbes and enzymes to produce and modify carbohydrates of potential and actual commercial value. These powerful methods enable both the expert and the beginner to generate polysaccharides, oligosaccharides, and carbohydrate-based surfactants by fermen

Carbohydrate Biotechnology Protocols
โœ Christopher Bucke (auth.), Christopher Bucke (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 1999 ๐Ÿ› Humana Press ๐ŸŒ English

<p>In Carbohydrate Biotechnology Protocols, Christopher Bucke has brought together a compilation of modern hands-on methods for the effective use of microbes and enzymes to produce and modify carbohydrates of potential and actual commercial value. These powerful methods enable both the expert and th

Carbohydrate Biotechnology Protocols
โœ Christopher Bucke ๐Ÿ“‚ Library ๐Ÿ“… 1999 ๐Ÿ› Humana Press ๐ŸŒ English

We are in a phase of the evolution of biotechnology in which the true and potential commercial importance of carbohydrates is becoming appre- ated more fully. Progress in providing hard facts to establish the commercial value ofpolysaccharides and oligosaccharides is limited, as always, by lack of f

Carbohydrate Biotechnology Protocols (Me
โœ Christopher Bucke (editor) ๐Ÿ“‚ Library ๐Ÿ“… 1999 ๐Ÿ› Humana ๐ŸŒ English

<span>We are in a phase of the evolution of biotechnology in which the true and potential commercial importance of carbohydrates is becoming appre- ated more fully. Progress in providing hard facts to establish the commercial value ofpolysaccharides and oligosaccharides is limited, as always, by lac